Lexicon Pharmaceuticals
LXRX
LXRX
137 hedge funds and large institutions have $453M invested in Lexicon Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 20 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
8% more funds holding
Funds holding: 127 → 137 (+10)
2.67% more ownership
Funds ownership: 77.17% → 79.84% (+2.7%)
4% less capital invested
Capital invested by funds: $471M → $453M (-$17.9M)
Holders
137
Holding in Top 10
2
Calls
$2.34M
Puts
$277K
Top Buyers
| 1 | +$17.6M | |
| 2 | +$8.13M | |
| 3 | +$2.06M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
+$1.9M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.39M |
Top Sellers
| 1 | -$61.1M | |
| 2 | -$11.8M | |
| 3 | -$4.54M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.63M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.15M |